UC‐MSCs inhibit GBM cell growth and cause apoptosis via activation of tumor necrosis factor‐related apoptosis‐inducing ligand (TRAIL), whereas AT‐MSCs promote cell growth. Here, TNFSF10 is linked to glioblastoma.